to scale back the risk of major cardiovascular functions including heart attack, stroke, or death in Older people with style two diabetic issues with acknowledged cardiovascular diseaseto lower the potential risk of kidney condition worsening, kidney failure (conclude-phase kidney disorder), and Loss of life as a result of cardiovascular disease in